- G30 -

Our Mission is to raise funds to support breast cancer research clinical trials education and patient care. Our Approach is Simple it starts with you. Feature Trial BRCAP A Randomized DoubleBlind PlaceboControlled MultiCenter International Phase 3 Study to Determine the Preventive Effect of Denosumab on Breast Cancer in Women Carrying a BRCA1 Germline Mutation Breaking it down Is there a nonsurgical way to reduce breast cancer risk in women with a BRCA1 mutation. Eligibility Criteria Treatments Drugs used Locations and Contacts 30 locations throughout the United States include Pittsburgh.